$SAVA

Cassava Sciences Advances Alzheimer’s Treatment with Promising Clinical Trials and Robust Financial Growth

$SAVA Cassava Sciences, Inc. (NASDAQ:SAVA) stands out in the biotechnology sector, focusing on developing treatments for neurodegenerative diseases, particularly Alzheimer’s…